Anti-SARS-CoV-2 Spike mAb (CR3022)

• CAT Number: I044221
• Purity: ≥95%

Anti-SARS-CoV-2 Spike mAb (CR3022)（Cat No.:I044221）is a human monoclonal antibody that targets the receptor-binding domain (RBD) of the spike (S) protein of SARS-CoV-2. Originally isolated for its cross-reactivity with SARS-CoV, CR3022 binds a conserved epitope on the spike protein, distinct from the ACE2 binding site. Though it does not block viral entry directly, it contributes to neutralization by destabilizing the spike protein conformation. CR3022 has been used extensively in research to study antibody responses, viral structure, and as a tool in diagnostic and therapeutic development against COVID-19.